Gluten Exposure Can Trigger a Silent Autoimmune Disorder in Celiac Disease: Five Case Reports

Farahnaz Safaei¹, Amir Sadeghi^1, , Pardis Ketabi Moghadam¹, Peyman Taheri² and Mehran Taheri³

¹Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

²Medical School, Mashhad University of Medical Science, Mashhad, Iran

³Medical School, Iran University of Medical Science, Tehran, Iran

Cite this paper:
Farahnaz Safaei, Amir Sadeghi, Pardis Ketabi Moghadam, Peyman Taheri and Mehran Taheri. Gluten Exposure Can Trigger a Silent Autoimmune Disorder in Celiac Disease: Five Case Reports. International Journal of Celiac Disease. 2023; 11(1):23-27. doi: 10.12691/ijcd-11-1-5

Abstract

People with celiac disease are at increased risk of developing other autoimmune disorders. Leaving the gluten-free diet not only causes the recurrence of celiac disease, but also increases the incidence of other autoimmune disorders. Here, we present 5 cases suffering from other autoimmune diseases in addition to background celiac disease. Careful and continuous monitoring of these patients can greatly prevent the occurrence of other autoimmune disorders.

Keywords:
celiac gluten free diet autoimmune disorder

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Lebwohl B, Rubio-Tapia A. Epidemiology, presentation, and diagnosis of celiac disease. Gastroenterology. 2021; 160(1): 63-75.
[2]	Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clinical gastroenterology and hepatology. 2018; 16(6): 823-36. e2.
[3]	Madan Mohan P, Ramesh T. Multiple autoimmune syndrome. Indian Journal of Dermatology Venereology and Leprology. 2003; 69: 298-9.
[4]	Zwolińska-Wcisło M, Galicka-Latała D, Rudnicka-Sosin L, Rozpondek P. Coeliac disease and other autoimmunological disorders coexistance. Przeglad Lekarski. 2009; 66(7): 370-2.
[5]	Prieto J, Singh KB, Nnadozie MC, Abdal M, Shrestha N, Abe RAM, et al. New Evidence in the Pathogenesis of Celiac Disease and Type 1 Diabetes Mellitus: A Systematic Review. Cureus. 2021; 13(7).
[6]	Bruzzese V, Scolieri P, Pepe J. Efficacy of gluten-free diet in patients with rheumatoid arthritis. Reumatismo. 2020; 72(4): 213-7.
[7]	Knezevic J, Starchl C, Tmava Berisha A, Amrein K. Thyroid-gut-axis: how does the microbiota influence thyroid function? Nutrients. 2020; 12(6): 1769.
[8]	Naseri K, Dabiri H, Rostami-Nejad M, Yadegar A, Houri H, Olfatifar M, et al. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC gastroenterology. 2021; 21(1): 1-14.
[9]	Ventura A, Magazu G, Gerarduzzi T, Greco L. Coeliac disease and the risk of autoimmune disorders. Gut. 2002; 51(6): 897-8.
[10]	Guidetti CS, Solerio E, Scaglione N, Aimo G, Mengozzi G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut. 2001; 49(4): 502-5.
[11]	Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nature medicine. 2001; 7(8): 899-905.
[12]	Harpreet S, Deepak J, Kiran B. Multiple autoimmune syndrome with celiac disease. Reumatologia/Rheumatology. 2016; 54(6): 326-9.
[13]	Valvano M, Longo S, Stefanelli G, Frieri G, Viscido A, Latella G. Celiac disease, gluten-free diet, and metabolic and liver disorders. Nutrients. 2020; 12(4): 940.
[14]	Ventura A, Magazzù G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology. 1999; 117(2): 297-303.
[15]	Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Official journal of the American College of Gastroenterology| ACG. 2010; 105(12): 2520-4.
[16]	Baharvand P, Hormozi M, Aaliehpour A. Comparison of thyroid disease prevalence in patients with celiac disease and controls. Gastroenterology and Hepatology from Bed to Bench. 2020; 13(1): 44.
[17]	Kurien M, Mollazadegan K, Sanders DS, Ludvigsson JF. Celiac disease increases risk of thyroid disease in patients with type 1 diabetes: a nationwide cohort study. Diabetes Care. 2016; 39(3): 371-5.
[18]	Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nature Reviews Immunology. 2009; 9(12): 858-70.
[19]	Sategna-Guidetti C, Volta U, Ciacci C, Usai P, Carlino A, De Franceschi L, et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. The American journal of gastroenterology. 2001; 96(3): 751-7.
[20]	Freeman HJ. Endocrine manifestations in celiac disease. World journal of gastroenterology. 2016; 22(38): 8472.
[21]	Lebwohl B, Söderling J, Roelstraete B, Lebwohl MG, Green PH, Ludvigsson JF. Risk of skin disorders in patients with celiac disease: A population-based cohort study. Journal of the American Academy of Dermatology. 2021; 85(6): 1456-64.
[22]	Zhang J-Z, Abudoureyimu D, Wang M, Yu S-R, Kang X-J. Association between celiac disease and vitiligo: A review of the literature. World Journal of Clinical Cases. 2021; 9(34): 10430.
[23]	Volta U, Bardazzi F, Zauli D, De Franceschi L, Tosti A, Mounaro N, et al. Serological screening for coeliac disease in vitiligo and alopecia areata. British Journal of Dermatology. 1997; 136(5): 801a-2.
[24]	Akbulut U, ÇEBİ A, Sag E, İkbal M, Cakir M. Interleukin-6 and interleukin-17 gene polymorphism association with celiac disease in children. Turkish Journal of Gastroenterology. 2017; 28(6).
[25]	Ecevit ÇÖ. Interleukin-6 and Interleukin-17 gene polymorphisms and celiac disease susceptibility. Turk J Gastroenterol. 2017; 28: 432-3.
[26]	Sushama S, Dixit N, Gautam RK, Arora P, Khurana A, Anubhuti A. Cytokine profile (IL‐2, IL‐6, IL‐17, IL‐22, and TNF‐α) in vitiligo—New insight into pathogenesis of disease. Journal of Cosmetic Dermatology. 2019; 18(1): 337-41.
[27]	Abdallah MA, Abdel-Hamid MF, Kotb AM, Mabrouk EA. Serum interferon-g is a psoriasis severity and prognostic marker. Cutis. 2009; 84(3): 163-8.
[28]	Nilsen EM, Jahnsen FL, Lundin KE, Johansen FE, Fausa O, Sollid LM, et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology. 1998; 115(3): 551-63.
[29]	Haggård L, Glimberg I, Lebwohl B, Sharma R, Verna EC, Green PH, et al. High prevalence of celiac disease in autoimmune hepatitis: Systematic review and meta‐analysis. Liver International. 2021; 41(11): 2693-702.
[30]	Panetta F, Nobili V, Sartorelli MR, Papa RE, Ferretti F, Alterio A, et al. Celiac Disease in Pediatric Patients with Autoimmune Hepatitis. Pediatric Drugs. 2012; 14(1): 35-41.
[31]	Zali MR, Nejad MR, Rostami K, Alavian SM. Liver complications in celiac disease. Hepatitis monthly. 2011; 11(5): 333.
[32]	Vajro P, Fontanella A, Mayer M, De Vincenzo A, Terracciano LM, D'Armiento M, et al. Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy. The Journal of pediatrics. 1993; 122(3): 416-9.